| |
PRZOOM - /newswire/ -
Baltimore, MD, United States, 2011/10/24 - On December 6, 2011, MET Labs will launch the Program for Testing Medical Devices for Susceptibility to RFID, to determine potential adverse events of radio frequency identification (RFID) emissions on electronic medical devices - METLabs.com.
|
| |
|
| |
Your Banner Ad Here instead - Showing along with ALL Articles covering Certification / Testing Announcements
Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!
|
| |
After months of development with AIM Healthcare Initiative (HCI) and the U.S. Food and Drug Administration (FDA), the Program’s test protocol can now undergo validation using actual medical devices. MET Labs is launching the program with a free informational webinar.
Medical device manufacturers are invited to participate by submitting representative devices to MET Labs for testing, which will take approximately one day to complete for each submitted device. Eligible medical devices are those covered by the IEC 60601 family of standards.
There are several benefits to participation. Submitted equipment will be tested in several different RFID frequency bands and participants will receive a confidential test report. If equipment is found to be susceptible to RF interference, MET Labs will assist manufacturers with strategies for minimizing or eliminating interference effects.
The confidentiality of manufacturer participation and individual test results will be strictly maintained. MET Labs will only share or publish aggregate, unattributed data that relates to the validation and/or further development of a final test protocol with the AIM RFID Experts Group. MET Labs will not share or publish any results without the explicit, written consent of the medical device manufacturer.
The increasing use of wireless monitoring devices in RF-rich environments (from RFID, wireless LANs and other devices) makes this research critical in the prevention of potential adverse effects from RFID emissions on patient safety.
Upon completion and acceptance by AIM, Inc., the final test protocol will be submitted to recognized national and international standards organizations so that it may be publically available.
Interested medical device manufacturers are asked to participate in a free informational webinar on December 6, 2011 that will provide more details about the program. Those interested but unable to attend should complete an online interested party form. Eligible form completers will receive a Program Information Packet that includes a sample test report.
|
| |
 |
| |
Your Banner Ad Here instead - Showing along with ALL Articles covering Certification / Testing Announcements
Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!
|
| |
Agency / Source: MET Laboratories, Inc.
|
| |
 |
| |
Availability: All Regions (Including Int'l)
|
| |
Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker
|
| |
Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]
|
| |
 |
| |
# # #
|
| |
|
| |
 |
| |
Your Banner Ad showing on ALL Certification / Testing articles, CATCH Visitors via Your Competitors Announcements!
 Company website links NOT available to basic submissions |
|
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source. |
| |
 |
| |
For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
MET Laboratories
| |
Contact: Press Office - METLabs.com
410-354-3300 info[.]metlabs.com
|